Accumulating evidence has also determined that rs662799 genetic variants located upstream of the APOA5 promoter are linked to hypertriglyceridemia and increase the risk of MetS with its individual components [18, 20, 58, 59]. This evidence concerns the gene APOA5 and hypertriglyceridemia.